Eltek Ltd 6-K, filed Nov 19, 2024
Eltek Ltd (ELTK)
6-K
2024-11-19
For: 2024-11-19
View Original
Added on
April 09, 2026
About this 6-K
Eltek Ltd filed this 6-K on November 19, 2024.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2024
Commission file number 000-28884
Eltek Ltd.
(Name of Registrant)
Sgoola Industrial Zone, Petach Tikva, Israel
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): *
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): *
Eltek Ltd.
EXPLANATORY NOTE
On November 19, 2024 Eltek issued a press release
reporting third quarter 2024 financial results. A copy of this press release is furnished herewith as Exhibit 99.1.
EXHIBIT INDEX
|
Exhibit
|
|
Description
|
|
|
|
|
|
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
|
ELTEK LTD.
|
|
|
(Registrant)
|
|
|
By: /s/Ron Freund
|
|
|
Ron Freund
|
|
|
Chief Financial Officer
|
Date: November 19, 2024
Exhibit 99.1
Press Release
Eltek Ltd. Reports 2024 Third Quarter Financial Results
Petach Tikva, Israel (November 19, 2024) Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs),
today announced its financial results for the quarter ended September 30, 2024.
Third Quarter 2024 Highlights
| ◾ |
Revenues were $13.5 million, up 14 % over Q3 2023
|
| ◾ |
Operating profit was $1.9 million
|
| ◾ |
Profit before tax was $2.0 million
|
| ◾ |
Net income was $1.7 million or $0.25 per fully diluted share
|
| ◾ |
As of September 30, 2024, cash and cash equivalents amounted $18.1 million
|
"In the third quarter of 2024, we delivered strong financial results. We generated a record of $13.5 million in sales, bringing our revenues to $35.8 million for the first three quarters of 2024
and twelve-month trailing revenues (TTM) of $48 million. Our gross profit for the quarter totaled $3.5 million, with a net profit of $1.7 million. The gross margin for the third quarter reached 26%, reflecting the alignment of our product mix with
market demand and the adjustment of production workers' wages to the current state of the local employment market. We continue to see robust demand across our two main customer segments: defense and aerospace, and medical devices. As of the end of
the quarter, our cash and cash equivalents stood at $18.1 million, providing significant financial support for our growth strategy," said Eli Yaffe, CEO of Eltek.
"Throughout the quarter, we also advanced our accelerated investment plan. By year-end 2024, we plan to open a new 15,000 sq. ft. manufacturing space in our facility, which will include a
state-of-the-art full Solder Mask Application line," Mr. Yaffe added.
"In response to continued demand for our products and our strong profitability, Eltek's Board of Directors has adopted a dividend policy, effective from 2024 year-end onwards. The policy will allow
for an annual distribution of up to 25% of our net income, as determined under US GAAP," concluded Mr. Yaffe.
Third Quarter 2024 GAAP Financial Results
Revenues for the third quarter of 2024 were $13.5 million, compared to $11.9 million in the third quarter of 2023, a 14% increase;
Gross profit for the third quarter of 2024 was $3.5 million (26% of revenues) compared to $3.7 million (31% of revenues) in the third quarter of 2023. Gross
margin in the third quarter of 2023 was exceptional due to sales orders which included an exceptional low material components;
Operating profit for the third quarter of 2024 was $1.9 million compared to operating profit of $2.3 million in the third quarter of 2023;
Income before income tax for the third quarter of 2024 was $2.0 million compared to $2.6 million in the third quarter of 2023;
Net income for the third quarter of 2024 was $1.7 million or $0.25 per fully diluted share compared to net income of $2.1 million or $0.36 per fully diluted
share in the third quarter of 2023.
Third Quarter 2024 Non-GAAP Financial Results
EBITDA for the third quarter of 2024 was $2.3 million (17% of revenues) compared to EBITDA of $2.6 million (22% of revenues) in the third quarter of 2023.
First Nine Months 2024 GAAP Financial Results
Revenues for the first nine months of 2024 were $35.8 million compared to $34.4 million in the first nine months of 2023;
Gross profit for the first nine months of 2024 was $8.4 million (23% of revenues) compared to $9.6 million (28% of revenues) in the first nine months of 2023;
Operating profit for the first nine months of 2024 was $4.0 million compared to operating profit of $5.3 million in the first nine months of 2023;
Financial income for the first nine months of 2024 was $1.0 million compared to financial income of $0.8 million in the first nine months of 2023.
Income before income tax for the first nine months of 2024 was $5.0 million compared to $6.0 million in the first nine months of 2023;
Net profit for the first nine months of 2024 was $4.2 million or $0.63 per fully diluted share compared to net profit of $5.0 million or $0.85 per fully
diluted share in the first nine months of 2023.
First Nine Months 2024 Non-GAAP Financial Results
EBITDA for the first nine months of 2024 was a $5.2 million (14% of revenues) compared to EBITDA of $6.2 million (18% of revenues) in the first nine months of 2023.
About our Non-GAAP Financial Information
The Company reports financial results in accordance with U.S. GAAP and herein provides some non-GAAP measures, including EBITDA. These non-GAAP measures are not in accordance with, nor are they a
substitute for, GAAP measures. These non-GAAP measures are intended to supplement the Company’s presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measures presented to evaluate and manage
the Company’s operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the Company's results on a GAAP and non-GAAP basis is provided in the table
below.
Conference Call
Today, Tuesday, November 19, 2024, at 9:00am Eastern Time (16:00pm Israel Time, 6:00am Pacific Time), Eltek will conduct a conference call to discuss the results. The call will feature remarks by
Eli Yaffe, Chief Executive Officer and Ron Freund, Chief Financial Officer.
To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:
|
United States:
|
1-866-860-9642
|
|
|
Israel:
|
03-918-0691
|
|
|
International:
|
+972-3-918-0691
|
To Access a Replay of the Call
A replay of the call will be available for 30 days on the Investor Info section on Eltek’s corporate website at http://www.nisteceltek.com approximately 24 hours after the conference call is completed.
About Eltek
Eltek – ”Innovation Across the Board”, is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), and is an Israeli leading company in
this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek is ITAR compliant and has
AS-9100 and NADCAP Electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.
Eltek was founded in 1970. The Company’s headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiary in North America and by agents and
distributors in Europe, India, South Africa and South America.
For more information, visit Eltek's web site at www.nisteceltek.com
Forward Looking Statement
Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future
quarters, the impact of Israel’s continuing war against Hamas and Hezbollah, the impact of the Coronavirus on the economy and our operations, risks in product and technology development and rapid technological change, product demand, the impact of
competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company’s Annual Report on Form 20-F and other filings with the United States Securities and Exchange
Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our website is not incorporated by reference into this press release and is included for reference
purposes only.
Investor Contact
Ron Freund
Chief Financial Officer
Investor-Contact@nisteceltek.com
Chief Financial Officer
Investor-Contact@nisteceltek.com
+972-3-939-5023
(Tables
follow)
|
Eltek Ltd.
|
|
Consolidated Statements of Income
|
|
U.S dollars in thousands (except per share data)
|
|
Three months ended
|
Nine months ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2024
|
2023
|
2024
|
2023
|
|||||||||||||
|
Revenues
|
13,520
|
11,861
|
35,769
|
34,374
|
||||||||||||
|
Costs of revenues
|
(10,003
|
)
|
(8,182
|
)
|
(27,364
|
)
|
(24,728
|
)
|
||||||||
|
Gross profit
|
3,517
|
3,679
|
8,405
|
9,646
|
||||||||||||
|
Research and development expenses, net
|
(17
|
)
|
(12
|
)
|
(79
|
)
|
(36
|
)
|
||||||||
|
Selling, general and administrative expenses
|
(1,592
|
)
|
(1,357
|
)
|
(4,292
|
)
|
(4,317
|
)
|
||||||||
|
Operating profit
|
1,908
|
2,310
|
4,034
|
5,293
|
||||||||||||
|
Financial income, net
|
137
|
279
|
976
|
756
|
||||||||||||
|
Income before income tax
|
2,045
|
2,589
|
5,010
|
6,049
|
||||||||||||
|
Income tax expenses
|
333
|
442
|
808
|
1,027
|
||||||||||||
|
Net income
|
1,712
|
2,147
|
4,202
|
5,022
|
||||||||||||
|
Earnings per share:
|
||||||||||||||||
|
Basic net profit per ordinary share
|
0.26
|
0.36
|
0.64
|
0.85
|
||||||||||||
|
Diluted net profit per ordinary share
|
0.25
|
0.36
|
0.63
|
0.85
|
||||||||||||
|
Weighted average number of ordinary shares used to compute
|
||||||||||||||||
|
basic net profit per ordinary share (in thousands)
|
6,710
|
5,914
|
6,597
|
5,890
|
||||||||||||
|
Weighted average number of ordinary shares used to compute
|
||||||||||||||||
|
diluted net profit per ordinary share (in thousands)
|
6,768
|
5,987
|
6,675
|
5,927
|
||||||||||||
|
Eltek Ltd.
|
|
Consolidated Balance Sheets
|
|
U.S dollars in thousands
|
|
September 30,
|
December 31,
|
|||||||
|
2024
|
2023
|
|||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
8,548
|
9,278
|
||||||
|
Short-term bank deposits
|
9,530
|
2,862
|
||||||
|
Receivables: Trade, net of provision for doubtful accounts
|
12,800
|
10,898
|
||||||
|
Other
|
83
|
689
|
||||||
|
Inventories
|
6,775
|
6,135
|
||||||
|
Prepaid expenses
|
225
|
245
|
||||||
|
Total current assets
|
37,961
|
30,107
|
||||||
|
Long term assets:
|
||||||||
|
Severance pay fund
|
56
|
57
|
||||||
|
Deferred tax asset, net
|
663
|
1,098
|
||||||
|
Operating lease right of use assets
|
5,933
|
6,555
|
||||||
|
Total long term assets
|
6,652
|
7,710
|
||||||
|
Fixed assets, less accumulated depreciation
|
14,166
|
9,354
|
||||||
|
Total Assets
|
58,779
|
47,171
|
||||||
|
Liabilities and Shareholder's equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable: Trade
|
6,166
|
7,503
|
||||||
|
Other
|
5,812
|
5,689
|
||||||
|
Short-term operating lease liabilities
|
799
|
789
|
||||||
|
Total current liabilities
|
12,777
|
13,981
|
||||||
|
Long-term liabilities:
|
||||||||
|
Employee severance benefits
|
436
|
447
|
||||||
|
Long-term operating lease liabilities
|
5,240
|
5,871
|
||||||
|
Total long-term liabilities
|
5,676
|
6,318
|
||||||
|
Shareholders' equity:
|
||||||||
|
Ordinary shares of NIS 3.0 par value – Authorized: 10,000,000 shares at September 30, 2024 and December 31, 2023; Issued and outstanding: 6,712,040 shares at September 30, 2024 and 6,020,693 shares at December
31, 2023
|
6,009
|
5,443
|
||||||
|
Additional paid-in capital
|
32,611
|
23,587
|
||||||
|
Cumulative foreign currency translation adjustments
|
(1
|
)
|
783
|
|||||
|
Capital reserve
|
2,346
|
1,900
|
||||||
|
Accumulated deficit
|
(639
|
)
|
(4,841
|
)
|
||||
|
Total shareholders' equity
|
40,326
|
26,872
|
||||||
|
Total liabilities and shareholders' equity
|
58,779
|
47,171
|
||||||
|
Eltek Ltd.
|
|
Unaudited Non-GAAP EBITDA Reconciliations
|
|
U.S dollars in thousands
|
|
Three months ended
|
Nine months ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2024
|
2023
|
2024
|
2023
|
|||||||||||||
|
GAAP net income
|
1,712
|
2,147
|
4,202
|
5,022
|
||||||||||||
|
Add back items:
|
||||||||||||||||
|
Financial income, net
|
(137
|
)
|
(279
|
)
|
(976
|
)
|
(756
|
)
|
||||||||
|
Income tax expenses
|
333
|
442
|
808
|
1,027
|
||||||||||||
|
Depreciation and amortization
|
388
|
299
|
1,141
|
929
|
||||||||||||
|
Non-GAAP EBITDA
|
2,296
|
2,609
|
5,175
|
6,222
|
||||||||||||
|
Eltek Ltd.
|
|
Consolidated Statement of Cash flow
|
|
U.S dollars in thousands
|
|
Three months ended
|
Nine months ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2024
|
2023
|
2024
|
2023
|
|||||||||||||
|
Cash flows from operating activities:
|
||||||||||||||||
|
Net Income
|
1,712
|
2,147
|
4,202
|
5,022
|
||||||||||||
|
Adjustments to reconcile net income to net cash flows
|
||||||||||||||||
|
provided by operating activities:
|
||||||||||||||||
|
Depreciation and amortization
|
388
|
299
|
1,141
|
929
|
||||||||||||
|
Accrued interest
|
115
|
-
|
(71
|
)
|
-
|
|||||||||||
|
Stock-based compensation
|
160
|
72
|
446
|
216
|
||||||||||||
|
Decrease in deferred tax assets and long term tax receivable
|
313
|
432
|
404
|
998
|
||||||||||||
|
976
|
803
|
1,920
|
2,143
|
|||||||||||||
|
Decrease (increase) in operating lease right-of-use assets
|
1
|
-
|
4
|
(22
|
)
|
|||||||||||
|
Decrease (increase) in trade receivables
|
(2,735
|
)
|
985
|
(2,218
|
)
|
(799
|
)
|
|||||||||
|
Decrease (increase) in other receivables and prepaid expenses
|
292
|
87
|
601
|
(224
|
)
|
|||||||||||
|
Decrease (increase) in inventories
|
(256
|
)
|
(47
|
)
|
(821
|
)
|
(856
|
)
|
||||||||
|
Increase (decrease) in trade payables
|
1,087
|
(74
|
)
|
551
|
31
|
|||||||||||
|
Increase (decrease) in other liabilities and accrued expenses
|
538
|
(263
|
)
|
289
|
1,214
|
|||||||||||
|
Increase (decrease) in employee severance benefits, net
|
32
|
11
|
2
|
33
|
||||||||||||
|
(1,041
|
)
|
699
|
(1,592
|
)
|
(623
|
)
|
||||||||||
|
Net cash provided by operating activities
|
1,647
|
3,649
|
4,530
|
6,542
|
||||||||||||
|
Cash flows from investing activities:
|
||||||||||||||||
|
Purchase of property and equipment
|
(1,967
|
)
|
(475
|
)
|
(7,914
|
)
|
(1,186
|
)
|
||||||||
|
Insurance Proceeds
|
-
|
-
|
-
|
2,000
|
||||||||||||
|
Investment in short-term bank deposits, net
|
(134
|
)
|
-
|
(6,668
|
)
|
-
|
||||||||||
|
Restricted deposits
|
-
|
-
|
-
|
192
|
||||||||||||
|
Net cash provided by (used in) investing activities
|
(2,101
|
)
|
(475
|
)
|
(14,582
|
)
|
1,006
|
|||||||||
|
Cash flows from financing activities:
|
||||||||||||||||
|
Exercise of options
|
17
|
29
|
278
|
328
|
||||||||||||
|
Repayment of long-term loans from bank
|
-
|
-
|
-
|
(3,348
|
)
|
|||||||||||
|
Issuance of shares, net
|
-
|
-
|
9,312
|
-
|
||||||||||||
|
Net cash provided by (used in) financing activities
|
17
|
29
|
9,590
|
(3,020
|
)
|
|||||||||||
|
Effect of translation adjustments
|
108
|
(228
|
)
|
(268
|
)
|
(589
|
)
|
|||||||||
|
Net increase (decrease) in cash and cash equivalents
|
(329
|
)
|
2,975
|
(730
|
)
|
3,939
|
||||||||||
|
Cash and cash equivalents at the beginning of the period
|
8,877
|
8,330
|
9,278
|
7,366
|
||||||||||||
|
Cash and cash equivalents at the end of the period
|
8,548
|
11,305
|
8,548
|
11,305
|
||||||||||||